| Literature DB >> 27936311 |
Wenpei Fan1,2,3, Nan Lu3, Peng Huang1, Yi Liu3, Zhen Yang3, Sheng Wang1, Guocan Yu3, Yijing Liu3, Junkai Hu4, Qianjun He1, Junle Qu2, Tianfu Wang1, Xiaoyuan Chen3.
Abstract
Glucose is a key energy supplier and nutrient for tumor growth. Herein, inspired by the glucose oxidase (GOx)-assisted conversion of glucose into gluconic acid and toxic H2 O2 , a novel treatment paradigm of starving-like therapy is developed for significant tumor-killing effects, more effective than conventional starving therapy by only cutting off the energy supply. Furthermore, the generated acidic H2 O2 can oxidize l-Arginine (l-Arg) into NO for enhanced gas therapy. By using hollow mesoporous organosilica nanoparticle (HMON) as a biocompatible/biodegradable nanocarrier for the co-delivery of GOx and l-Arg, a novel glucose-responsive nanomedicine (l-Arg-HMON-GOx) has been for the first time constructed for synergistic cancer starving-like/gas therapy without the need of external excitation, which yields a remarkable H2 O2 -NO cooperative anticancer effect with minimal adverse effect.Entities:
Keywords: hydrogen peroxide; mesoporous nanomaterials; nitric oxide; synergistic therapy; ultrasound imaging
Mesh:
Substances:
Year: 2016 PMID: 27936311 DOI: 10.1002/anie.201610682
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336